Healing observed at week 12 was 75 % vs. 58 % ( p = 0.1 ) ; at week 18 it was 94 % vs. 80 % ( p = 0.15 ) ; and at week 24 it was 94 % vs. 87 % ( p = 0.43 ) for the device group and the placebo group , respectively .